Back to top

Image: Bigstock

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

Read MoreHide Full Article

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.

USANA Health Sciences (USNA - Free Report) is a stock many investors are watching right now. USNA is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A.

We also note that USNA holds a PEG ratio of 0.78. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. USNA's PEG compares to its industry's average PEG of 2.17. Over the past 52 weeks, USNA's PEG has been as high as 1.39 and as low as 0.65, with a median of 0.87.

Another valuation metric that we should highlight is USNA's P/B ratio of 1.04. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 1.56. Over the past 12 months, USNA's P/B has been as high as 1.49 and as low as 0.83, with a median of 1.12.

Finally, investors will want to recognize that USNA has a P/CF ratio of 8.43. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. USNA's P/CF compares to its industry's average P/CF of 13.98. USNA's P/CF has been as high as 10.82 and as low as 7.18, with a median of 9.15, all within the past year.

These are just a handful of the figures considered in USANA Health Sciences's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that USNA is an impressive value stock right now.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in